Literature DB >> 1247523

Inhibition of bovine factor IXa and factor Xabeta by antithrombin III.

K Kurachi, K Fujikawa, G Schmer, E W Davie.   

Abstract

Factor IXa and factor Xabeta are serine proteases which participate in the middle phase of blood coagulation. These two enzymes are inhibited by antithrombin III by the formation of an enzyme-inhibitor complex containing 1 mol of enzyme and 1 mol of antithrombin III. The complex was readily demonstrated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and loss of coagulant or esterase activity at increasing concentrations of inhibitor. The inactivation of factor IXa by antithrombin III was relatively slow, but the reaction was greatly accelerated by the addition of heparin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1247523     DOI: 10.1021/bi00647a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  In vitro and in vivo correlation of clotting protease activity: effect of heparin.

Authors:  S N Gitel; R C Stephenson; S Wessler
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

Review 2.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

3.  The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.

Authors:  E Holmer; K Kurachi; G Söderström
Journal:  Biochem J       Date:  1981-02-01       Impact factor: 3.857

4.  Oligosaccharides from depolymerized fucosylated glycosaminoglycan: Structures and minimum size for intrinsic factor Xase complex inhibition.

Authors:  Ronghua Yin; Lutan Zhou; Na Gao; Zi Li; Longyan Zhao; Feineng Shang; Mingyi Wu; Jinhua Zhao
Journal:  J Biol Chem       Date:  2018-07-20       Impact factor: 5.157

5.  A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.

Authors:  D M Stern; P P Nawroth; W Kisiel; D Handley; M Drillings; J Bartos
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

6.  Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.

Authors:  J F Eidt; P Allison; S Noble; J Ashton; P Golino; J McNatt; L M Buja; J T Willerson
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

7.  Activation of human factor IX (Christmas factor).

Authors:  R G Di Scipio; K Kurachi; E W Davie
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

8.  Expression of functionally active human antithrombin III.

Authors:  A W Stephens; A Siddiqui; C H Hirs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

9.  Cloning of the full-length cDNA of porcine antithrombin III and comparison with its human homolog.

Authors:  Younan Chen; Weidong Tan; Shengfang Qin; Jie Zhang; Hong Bu; Youping Li; Yanrong Lu; Jingqiu Cheng
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

10.  Kinetic solvent isotope effects on the deacylation of specific acyl-papains. Proton inventory studies on the papain-catalysed hydrolyses of specific ester substrates: analysis of possible transition state structures.

Authors:  R J Szawelski; C W Wharton
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.